Is the efflux pump inhibitor Verapamil a potential booster for isoniazid against Mycobacterium tuberculosis?. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 56, p. e18309 , 2020. DOI: 10.1590/s2175-97902020000218309. Disponível em: https://www.revistas.usp.br/bjps/article/view/182070.. Acesso em: 28 may. 2024.